Empatica

🚀 Today we’re announcing our integration of Mobilise-D's digital mobility outcomes into the Empatica Health Monitoring Platform, providing 25 new validated measures for COPD, Parkinson’s disease, multiple sclerosis, hip fracture recovery, and congestive heart failure. Mobilise-D is a consortium funded under the EU Innovative Medicines Initiative and EFPIA partners, to develop a novel method to accurately and reliability assess change in one’s mobility in the real-world environment using digital technologies. “We are proud to be the first company to implement the Mobilise-D consortium’s groundbreaking development and validation work”, said our CTO and Co-Founder, Simone Tognetti. “The demand for high-quality, purpose-specific measures is immense, and Empatica is ready to support the dissemination of the consortium’s innovative work within the industry.” Read our press release ➡️ https://lnkd.in/dNYhNWV5 #WearableTechnology #DigitalBiomarkers

📖 Are you looking for publications examining specific therapeutic areas, conditions, study types or participant ages? Easily search for studies using Empatica’s technology on our publications page. Discover Empatica’s publications: https://lnkd.in/denZuF7s

Recently, we had the opportunity to interview Dr. Matthew S. Goodwin, an Interdisciplinary Professor with over 25 years of experience in autism research. He shared the findings from his study exploring whether #WearableTechnology, such as Empatica’s tech, could be used to predict aggressive behavior in children with profound #autism before aggressive behavior happened. Read in full ➡️ https://lnkd.in/d5Zq-eub #AutismResearch 

What’s the value of medical devices with clinically validated algorithms and measures vs. consumer wearables? ✅ In order to ensure that Empatica’s digital biomarkers are reliable, the algorithms are clinically validated against a gold standard measure. This makes data collected by the EmbracePlus wearable reliable and clinically actionable. ❌ Whereas consumer wearables tend to have black box algorithms, meaning they do not reveal how a measure is calculated and this could even be changed without warning. Discover more on EmbracePlus: https://lnkd.in/dBGs7q6C #WearableTechnology #MedicalWearable #WearableTech

🎓 We’re pleased to share that due to popular demand, we’ve extended the application deadline for the 2024 Empatica #Engineering Graduate Program! Successful candidates will have the opportunity to rotate through various software domains including Mobile Development, Backend and Web Development, and Software Automation. Plus you’ll benefit from: 🤝🏽 Hands-on experience 🧑🏽🤝🧑🏻 Mentorship from talented peers 🚀 Contribute to real projects that drive our company's success #ApplyToday: https://lnkd.in/dPfMKuHR #ApplyNow #LifeAtEmpatica #WearableTechnology

⏰ Don’t delay! Apply for the Empatica Engineering Graduate Program before applications close on July 31st 2024. 🎓 2 graduate students will be given the opportunity to dive into the intricacies of digital healthcare, solving real problems while joining a team of young, friendly, and international people. Apply today: https://lnkd.in/dZ6w4HDU #ApplyNow #ApplyToday #LifeAtEmpatica #WearableTechnology #Engineering

⌚EmbracePlus, part of the FDA-cleared Empatica Health Monitoring Platform, is a highly versatile wearable and can be worn in a variety of body positions depending on your study needs. #WearableTechnology #DigitalBiomarkers #Wearables 

Last month our Chief Medical Officer, Marisa Cruz, M.D., joined the FDA’s and Digital Medicine Society (DiMe)’s co-sponsored public workshop. This workshop aimed to show how patient-generated health data can promote medical device innovation throughout the total product life cycle. Watch the full workshop, including Marisa’s presentation ‘Measuring Sparks of Brilliance: Newer Modalities of Epilepsy Monitoring’, here: https://lnkd.in/dQgVkHQt 

📊 Cast your vote in our #ThisOrThat poll. We put this question to our colleagues at Empatica and listening to much was a clear winner. Some studies have found that music helps to increase productivity, and our technology was even used in a study to turn your moods and emotions into music.

In case you missed it, we recently announced our partnership with McRoberts BV, incorporating all 71 of their endpoints in our digital biomarkers portfolio, bringing our total digital biomarker offering to 200+. ➡️ Discover our partnership: https://lnkd.in/dcK7rUgV #DigitalBiomarkers #WearableTechnology